Notice Type
Departmental
Notice Title

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Fuzeon
Active Ingredient: Enfuvirtide 108mg
Dosage Form: Powder for injection
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche Limited, Basel, Switzerland
Pfizer Inc, Kalamazoo, Michigan, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Product: Zevalin
Active Ingredient: Ibritumomab tiuxetan 1.6mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Schering (NZ) Limited
Manufacturer: Baxter Pharmaceutical Solutions LLC, Bloomington, Indiana, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 2nd day of March 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).